ATAI insider transactions
AtaiBeckley Inc. (ATAI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
ATAI insiders
Everyone who has filed a Form 3, 4, 5 or 144 at AtaiBeckley Inc., latest first. Follow anyone to get their next filing.
- Gerd KochendoerferChief Operating Officer, since December 2024-$250K
- Kevin James CraigChief Medical Officer, since January 2025-$421K
- Laurent FischerDirector, since May 2024
- Srinivas RaoOfficer, Director-$216K
- Andrea Heslin SmileyDirector
- Scott BraunsteinDirector, since May 2024
- Robert HershbergDirector, since November 2025-$496K
- Christian AngermayerDirector, 10% owner, since June 2021
- Sabrina Martucci JohnsonDirector
- Anne Nagengast JohnsonChief Accounting Officer, since May 2023-$96K
- Michael E. FaermChief Financial Officer
- John Francis HoffmanDirector, since May 2025
- Glenn Frank ShortChief Scientific Officer, since January 2025-$17.8K
- Barrett Christopher Ryan CaveOfficer, since October 2025
- Amir H KalaliDirector
- Cosmo Feilding-MellenDirector, since November 2025
- Apeiron Investment Group Ltd.10% owner, since June 2021+$48.9M
- Sahil KirpekarChief Business Officer, since November 2022-$132K
- Florian BrandOfficer+$185K-$291K
- Michael AuerbachDirector
- ATAI Life Sciences N.V.10% owner
- Jason CammDirector
- Stephen BardinOfficer, since August 2022
- Rolando Gutierrez-EsteinouOfficer
- Alexis de RosnayDirector
- Gregory L WeaverOfficer
Recent Form 3, 4, and 5 filings for ATAI
- Chief Medical Officer Craig Kevin James returned 8,437 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Kochendoerfer Gerd (for withholding tax)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Officer Barrett Christopher Ryan Cave returned 155,066 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Chief Scientific Officer Short Glenn Frank returned 42,333 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Hoffman John Francis to satisfy tax liability4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Faerm Michael E. to cover taxes4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Chief Accounting Officer Johnson Anne Nagengast returned 140,045 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Johnson Sabrina Martucci (withholding tax)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Director Angermayer Christian returned 55,756,748 shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Hershberg Robert to satisfy tax liability4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott (tax liability)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Director Smiley Andrea Heslin returned 4,666 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax liability)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Officer Rao Srinivas returned 216,442 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Fischer Laurent (for tax liability)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Director Kalali Amir H returned 4,666 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding obligation4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Director Hershberg Robert exercised 100,000 shares at a strike of $1.35 and sold $496,000 worth of shares (100,000 units at $4.96) as part of a pre-agreed trading plan (SEC Form 4)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Chief Medical Officer Craig Kevin James exercised 42,579 shares at a strike of $1.43 and sold $192,031 worth of shares (42,579 units at $4.51) as part of a pre-agreed trading plan (SEC Form 4)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- Chief Operating Officer Kochendoerfer Gerd exercised 50,000 shares at a strike of $1.60 and sold $250,000 worth of shares (50,000 units at $5.00) as part of a pre-agreed trading plan (SEC Form 4)4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Angermayer Christian4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Fischer Laurent4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Kalali Amir H4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Hoffman John Francis4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Smiley Andrea Heslin4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Johnson Sabrina Martucci4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Hershberg Robert4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Craig Kevin James4 - AtaiBeckley Inc. (0002081043) (Issuer)
- SEC Form 4 filed by Director Feilding-Mellen Cosmo4 - Atai Beckley N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Hershberg Robert4 - Atai Beckley N.V. (0001840904) (Issuer)
- Director Feilding-Mellen Cosmo was granted 7,702,990 shares (SEC Form 4)4 - Atai Beckley N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott4 - Atai Beckley N.V. (0001840904) (Issuer)
- SEC Form 3 filed by new insider Hershberg Robert3 - Atai Beckley N.V. (0001840904) (Issuer)
- SEC Form 3 filed by new insider Feilding-Mellen Cosmo3 - Atai Beckley N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Officer Barrett Christopher Ryan Cave4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- New insider Barrett Christopher Ryan Cave claimed ownership of 155,066 shares (SEC Form 3)3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Large owner Apeiron Investment Group Ltd. converted options into 2,367,200 shares (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Large owner Apeiron Investment Group Ltd. bought $19,000,000 worth of shares (8,675,799 units at $2.19) (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Officer Rao Srinivas4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Hoffman John Francis4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Johnson Sabrina Martucci4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Kalali Amir H4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Smiley Andrea Heslin4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Fischer Laurent4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Angermayer Christian4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Director Angermayer Christian4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 3 filed by new insider Hoffman John Francis3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Scientific Officer Short Glenn Frank sold $17,767 worth of shares (13,161 units at $1.35), decreasing direct ownership by 24% to 42,333 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Business Officer Kirpekar Sahil sold $65,560 worth of shares (48,563 units at $1.35), decreasing direct ownership by 30% to 115,636 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Financial Officer Johnson Anne Nagengast sold $45,286 worth of shares (33,545 units at $1.35), decreasing direct ownership by 19% to 140,045 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Officer Rao Srinivas sold $101,814 worth of shares (75,418 units at $1.35), decreasing direct ownership by 26% to 212,942 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Medical Officer Craig Kevin James sold $15,610 worth of shares (11,563 units at $1.35), decreasing direct ownership by 58% to 8,437 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Large owner Apeiron Investment Group Ltd. bought $2,520,000 worth of shares (1,800,000 units at $1.40) (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Officer Rao Srinivas converted options into 175,000 shares, increasing direct ownership by 154% to 288,360 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Scientific Officer Short Glenn Frank converted options into 32,500 shares, increasing direct ownership by 141% to 55,494 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Medical Officer Craig Kevin James converted options into 20,000 shares (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Business Officer Kirpekar Sahil converted options into 100,000 shares, increasing direct ownership by 156% to 164,199 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- Chief Financial Officer Johnson Anne Nagengast converted options into 100,000 shares, increasing direct ownership by 136% to 173,590 units (SEC Form 4)4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Short Glenn Frank4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Craig Kevin James4 - ATAI Life Sciences N.V. (0001840904) (Issuer)